{"id":"W3167842465","doi":"10.1016/s2352-4642(21)00100-0","title":"Treatment of infantile-onset spinal muscular atrophy with nusinersen: final report of a phase 2, open-label, multicentre, dose-escalation study","year":2021,"lang":"en","type":"article","venue":"The Lancet Child & Adolescent Health","topic":"Neurogenetic and Muscular Disorders Research","field":"Medicine","cited_by":104,"is_retracted":false,"has_abstract":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"Ionis Pharmaceuticals; Biogen","keywords":"Medicine; Spinal muscular atrophy; Interim analysis; Tolerability; Adverse effect; Cohort; Pediatrics; Clinical endpoint; Cohort study; Clinical trial; Surgery; Physical therapy; Internal medicine; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003771508,0.0002193141,0.0008685891,0.00007888104,0.0001475625,0.00002020597,0.0001884944,0.00003681606,0.00003175152],"category_scores_gemma":[0.00005309506,0.0001379373,0.00009278511,0.0004404995,0.0001332938,0.00004031915,0.0001044488,0.0002782476,0.000003274291],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00009128197,"about_ca_system_score_gemma":0.0008442634,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004026603,"about_ca_topic_score_gemma":0.0001636265,"domain_scores_codex":[0.9975337,0.0003568954,0.0005915806,0.0004347191,0.0006590298,0.0004241122],"domain_scores_gemma":[0.998144,0.00002180878,0.0003557856,0.001040815,0.0002513502,0.000186188],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03333312,0.1050718,0.7431209,0.002627765,0.001490478,0.003456033,0.004378953,0.0001348816,0.002703596,0.0001170709,0.001454181,0.1021112],"study_design_scores_gemma":[0.08131333,0.01696888,0.8867249,0.001069318,0.0004775873,0.002021756,0.001737142,0.0006248516,0.001326326,0.000005859131,0.007500692,0.0002292865],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9879831,0.002082211,0.000174778,0.006282319,0.00006704476,0.003097853,0.00003310308,0.00001882822,0.0002607506],"genre_scores_gemma":[0.9966896,0.001591816,0.0007474272,0.0005044025,0.0002187207,0.00003272832,0.0001114412,0.00002935102,0.00007455399],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.143604,"threshold_uncertainty_score":0.5624918,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.09361085090664703,"score_gpt":0.4152197734540647,"score_spread":0.3216089225474177,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}